Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Atherosclerosis|August 5, 2000
Prospective randomised cross-over comparison of three LDL-apheresis systems in statin pretreated patients with familial hypercholesterolaemiaS Schmaldienst, S Banyai, T M Stulnig, et al.British Journal of Haematology|February 13, 2001
Treatment of coagulation inhibitors with extracorporeal immunoadsorption (Ig-Therasorb)M Jansen, S Schmaldienst, S Banyai, et al.European Journal of Clinical Pharmacology|June 15, 2000
Multiple-dose pharmacokinetics of cefepime in long-term hemodialysis with high-flux membranesS Schmaldienst, F Traunmüller, H Burgmann, et al.European Journal of Immunology|April 1, 1993
Reactive oxygen product formation after Fc gamma receptor-mediated neutrophil activation by monomeric mouse IgG2a: implications for the generation of first dose effects after OKT3 treatmentG J Zlabinger, A R Rosenkranz, S Schmaldienst, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 21, 1998
Adrenal function in patients with chronic renal failureM Clodi, M Riedl, S Schmaldienst, et al.Annals of the Rheumatic Diseases|January 11, 2005
IgG immunoadsorption reduces systemic lupus erythematosus activity and proteinuria: a long term observational studyG H Stummvoll, M Aringer, J S Smolen, et al.Kidney International|February 13, 1999
Effects of sodium nitroprusside on hemodialysis-induced platelet activationB Jilma, N Hergovich, P Stohlawetz, et al.Journal of Clinical Immunology|May 1, 1992
Cytokine release and dynamics of leukocyte populations after CD3/TCR monoclonal antibody treatmentG J Zlabinger, K M Stuhlmeier, R Eher, et al.Clinical Pharmacology and Therapeutics|December 1, 1996
Multiple-dose pharmacokinetics of cefpirome in long-term hemodialysis with high-flux membranesF Thalhammer, S Schmaldienst, I Elmenyawi, et al.Pageof 2